Literature DB >> 17143069

Cardiovascular and renal actions of melanocyte-stimulating hormone peptides.

Michael H Humphreys1.   

Abstract

PURPOSE OF REVIEW: Melanocyte stimulating hormones (MSHs, melanocortins) have important roles in feeding and energy metabolism and in inflammation. Recent observations have uncovered major functions for these peptides, particularly gamma-MSH, in cardiovascular regulation and sodium metabolism. RECENT
FINDINGS: Both alpha- and gamma-MSH acutely elevate blood pressure and heart rate through central stimulation of sympathetic nervous outflow. This action of alpha-MSH is mediated by the melanocortin 4 receptor (MC4R), whereas sympathetic nervous stimulation by gamma-MSH does not involve its receptor MC3R but rather is likely due to activation of a sodium channel in the central nervous system. In contrast, gamma-MSH deficiency in rodents, or disruption of MC3R, leads to marked salt-sensitive hypertension, again through a central mechanism: a small dose of exogenous peptide delivered into the cerebroventricular system of mice with gamma-MSH deficiency restores blood pressure to normal. This salt-sensitive hypertension is accompanied by the development of insulin resistance; the mechanism linking these two consequences of a high-salt diet is not yet known but may involve activation of the sympathetic nervous system.
SUMMARY: The study of MSH peptides in blood pressure regulation offers a new opportunity to gain insight into the mechanisms underlying salt sensitivity and its link to insulin resistance, and to new therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143069     DOI: 10.1097/MNH.0b013e3280117fb5

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  13 in total

1.  Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet.

Authors:  X-P Ni; Michael H Humphreys
Journal:  Am J Hypertens       Date:  2008-09-18       Impact factor: 2.689

Review 2.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

3.  γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.

Authors:  Christine G Joseph; Hua Yao; Joseph W Scott; Nicholas B Sorensen; Rebecca N Marnane; Kathleen G Mountjoy; Carrie Haskell-Luevano
Journal:  Peptides       Date:  2010-09-15       Impact factor: 3.750

Review 4.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 5.  Physiological roles of the melanocortin MC₃ receptor.

Authors:  Benjamin J Renquist; Rachel N Lippert; Julien A Sebag; Kate L J Ellacott; Roger D Cone
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

6.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

7.  Microinjections of alpha-melanocyte stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated bradycardia.

Authors:  Vineet C Chitravanshi; Suresh Bhatt; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

8.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

9.  Laurdan spectrum decomposition as a tool for the analysis of surface bilayer structure and polarity: a study with DMPG, peptides and cholesterol.

Authors:  Aline D Lúcio; Cíntia C Vequi-Suplicy; Roberto M Fernandez; M Teresa Lamy
Journal:  J Fluoresc       Date:  2010-03       Impact factor: 2.217

10.  Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone.

Authors:  Xi-Ping Ni; Claudia van Dijk; David Pearce; Michael H Humphreys
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.